Q3 2020 Holdings
Filed 2020-11-13 | 157 holdings | $247.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $171.3M | 1,109,874 | 69.3% |
| Abbvie Inc(ABBV) | COMM | 00287Y109 | $29.9M | 341,340 | 12.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $19.7M | 258,653 | 8.0% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $8.0M | 434,555 | 3.2% |
| Cytokinetics Inc(CYTK) | COMM | 23282W605 | $7.6M | 349,296 | 3.1% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $4.9M | 1,911,573 | 2.0% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $2.7M | 793,054 | 1.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COMM | 004225108 | $2.0M | 48,996 | 0.8% |
| Natera(NTRA) | COMM | 632307104 | $224.0K | 3,100,560 | 0.1% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $151.0K | 1,952,441 | 0.1% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $84.2K | 2,194,278 | 0.0% |
| Inozyme Pharma, Inc. | COMM | 45790W108 | $53.3K | 2,028,308 | 0.0% |
| Checkmate Pharmaceuticals Inc | COMM | 162818108 | $41.5K | 3,606,707 | 0.0% |
| Amgen IncCall | COMM | 031162900 | $41.2K | 59,500 | 0.0% |
| Akouos, Inc | ADR | 00973J101 | $34.7K | 1,515,073 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $32.4K | 320,959 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $29.0K | 5,599,999 | 0.0% |
| Amgen Inc(AMGN) | COMM | 031162100 | $28.4K | 111,619 | 0.0% |
| Galera Therapeutics, Inc(GRTX) | COMM | 36338D108 | $27.9K | 3,083,712 | 0.0% |
| Nextcure, Inc | COMM | 65343E108 | $23.5K | 2,671,856 | 0.0% |
| Lilly Eli & Co(LLY) | COMM | 532457108 | $21.1K | 142,432 | 0.0% |
| Insmed Inc(INSM) | COMM | 457669307 | $19.8K | 615,143 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $18.9K | 405,152 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | COMM | G50871105 | $18.6K | 130,268 | 0.0% |
| Merck & Co Inc(MRK) | COMM | 58933Y105 | $15.8K | 190,559 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $15.7K | 1,311,039 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COMM | 46116X101 | $12.9K | 503,555 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GBOOBYWYV | $12.4K | 2,400,000 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $11.8K | 4,749,623 | 0.0% |
| Athira Pharma, Inc. | COMM | 04746L104 | $9.4K | 509,168 | 0.0% |
| Marinus Pharmaceuticals IncCall | COMM | 56854Q900 | $9.0K | 175,000 | 0.0% |
| Otonomy Inc | COMM | 68906L105 | $8.6K | 2,111,596 | 0.0% |
| GW Pharmaceuticals PLC | ADR | 36197T103 | $8.1K | 82,944 | 0.0% |
| Zymeworks Inc | COMM | 98985W102 | $7.1K | 151,902 | 0.0% |
| Cytokinetics IncPut | COMM | 23282W955 | $7.0K | 325,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COMM | 74366E102 | $7.0K | 357,769 | 0.0% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $6.9K | 225,259 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COMM | 868459108 | $6.9K | 330,295 | 0.0% |
| TG Therapeutics Inc(TGTX) | COMM | 88322Q108 | $6.7K | 250,401 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $6.7K | 59,546 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $6.7K | 68,615 | 0.0% |
| MyoKardia Inc | COMM | 62857M105 | $6.7K | 48,998 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COMM | 040047607 | $6.6K | 88,150 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COMM | 690469101 | $6.3K | 1,097,621 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COMM | 604749101 | $6.2K | 321,252 | 0.0% |
| Reata Pharmaceuticals IncPut | COMM | 75615P953 | $5.8K | 60,000 | 0.0% |
| Novocure LtdCall | COMM | G6674U908 | $5.6K | 50,000 | 0.0% |
| Amarin Corp | ADR | 023111206 | $4.9K | 1,170,584 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COMM | 74587V107 | $4.8K | 475,982 | 0.0% |
| Chiasma(CHMA) | COMM | 16706W102 | $4.5K | 1,047,354 | 0.0% |